TY  - CHAP
M1  - Book, Section
TI  - Management of the Critically Ill Patient with HIV/AIDS
A1  - Schrantz, Stephen
A1  - Czapar, Anna
A1  - Karmarkar, Ellora
A1  - Lew, Allison
A1  - MacKenzie, Erica
A1  - Petit, Natasha
A2  - Schmidt, Gregory A.
A2  - Kress, John P.
A2  - Douglas, Ivor S.
Y1  - 2023
N1  - 
T2  - Hall, Schmidt and Wood’s Principles of Critical Care, 5<sup>th</sup> Edition
AB  - KEY  POINTSCombination  antiretroviral  therapy  (cART)  has  been  shown  to  prolong  survival  and  disease-free  interval.  Interruption  in  adherence  to  treatment  is  a  major  risk  for  opportunistic  infections  (OIs)  leading  to  critical  care  needs.Because  of  better  treatment  and  prolonged  survival,  more  patients  are  admitted  to  the  ICU  who  have  HIV/AIDS  as  an  underlying  illness  as  opposed  to  the  cause  of  ICU  admission.Assessment  of  immunologic  functioning  via  measurement  of  CD4+  lymphocytes  is  fundamental  in  determining  risk  for  OIs.Continuation  or  initiation  of  cART  during  the  period  of  critical  illness  is  dependent  on  the  ability  to  tolerate  treatment  and  presence  or  absence  of  certain  OIs.  Presence  of  an  immune  reconstitution  inflammatory  syndrome  should  often  be  considered.Proper  diagnosis  of  OI  is  important  to  initiate  prompt  targeted  treatment.Recognition  of  the  social  aspects  of  the  patient’s  care  that  lead  to  critical  illness  is  important  to  reduce  re-admissions  and  complications  in  the  care  of  the  patient.  
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/10/15
UR  - accesssurgery.mhmedical.com/content.aspx?aid=1201805692
ER  -